Adalimumab induced alopecia areata in a patient with arthritis.

Authors

  • A.T. Aydemir
  • A. Oktem
  • P.O. Avar Aydın
  • Z.B. Özcakar
  • N. Kundakcı

DOI:

https://doi.org/10.26326/2281-9649.34.1.2550

Keywords:

adalimumab, pediatrics, alopecia areata

Abstract

The use of biologic agents such as anti-TNF alpha inhibitors in chronic inflammatory diseases is increasing. Consequently, skin side effects such as infusion reactions, psoriasis and alopecia have been observed. Knowing how to recognize these side effects is necessary to reach the correct diagnosis and treatment.

Downloads

Published

2024-01-29

How to Cite

Aydemir, A., Oktem, A., Avar Aydın, P., Özcakar, Z., & Kundakcı, N. (2024). Adalimumab induced alopecia areata in a patient with arthritis. European Journal of Pediatric Dermatology, 34(1), 51–3. https://doi.org/10.26326/2281-9649.34.1.2550

Issue

Vol. 34 No. 1 (2024)

Section

Original articles